TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial March 28, 2014
TCL Archive Ethics Commission Acknowledges Weak Case For Mandatory Patient Compensation April 23, 1982
TCL Archive King Named Lombardi Center Deputy Director; SWOG Needs New Exec; Murphy Leaves St. Jude July 22, 1988
